CCND1 and breast cancer: Furthermore, AGR2 has been shown to promote cell cycle progression via induction of cell cycle proteins such as cyclin D1, and extracellular AGR2 knockdown using anti-AGR2 antibodies in three ER+ breast cancer cell lines significantly reduces cyclin D1 protein levels and cell growth [17].